Kiplinger

8 Great Biotech ETFs to Buy

Biotech stocks typically are considered one of Wall Street's more aggressive sources of growth. These companies spend years and gobs of money to create breakthrough biological treatments and diagnostic tools, and successful developments can literally change their fortunes - and the fortunes of shareholders - overnight.

The flipside? Many of these companies generate no revenues, and are reliant on just one or two products to change that. Thus, failure to receive FDA approval can put their very existence at risk, and any setbacks often result in swift, stark losses.

Typically, this risk scenario puts biotech stocks on the outs when the market is volatile and investors are looking to go on the defensive. But so far through the first months of a very shaky 2018 in which the markets are essentially flat, most biotech exchange-traded funds are actually beating the market soundly.

It makes sense. While Wall Street might be worried about a trade war with China or tensions in Syria, these biotech companies still are running clinical trials, and still generating interest from larger pharmaceutical companies that are looking to buy their way to more robust pipelines.

Biotech ETFs are a safer way to buy into the space than individual companies. By investing in a

You're reading a preview, sign up to read more.

More from Kiplinger

Kiplinger18 min read
25 Dividend Stocks That Analysts Love the Most
The longest bull market in history keeps charging. Stocks are near record highs, which sounds good, but it does create a problem for income investors. Specifically, where can they find dividend stocks poised for outperformance that still sport decent
Kiplinger5 min readPolitics
To Gift or Not to Gift
In estate planning, giving away assets during your lifetime has traditionally been used to help lower estate taxes when you die. However, the federal estate tax exemption amount (the amount under which federal estate taxes do not apply) is currently
Kiplinger4 min read
Retirees: Don't Make the Same Mistakes Before a Market Correction
There's no doubt that earlier this year, many retirees I met with were in panic after the government shutdown. Even worse, economists have been warning the country could sink into a full-on recession before too long. With the recent swings in the Dow